2020
DOI: 10.15252/embr.201949123
|View full text |Cite
|
Sign up to set email alerts
|

HMCES safeguards replication from oxidative stress and ensures error‐free repair

Abstract: Replication across oxidative DNA lesions can give rise to mutations that pose a threat to genome integrity. How such lesions, which escape base excision repair, get removed without error during replication remains unknown. Our PCNA‐based screen to uncover changes in replisome composition under different replication stress conditions had revealed a previously unknown PCNA‐interacting protein, HMCES/C3orf37. Here, we show that HMCES is a critical component of the replication stress response, mainly upon base mis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
32
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(37 citation statements)
references
References 68 publications
(80 reference statements)
4
32
1
Order By: Relevance
“…In addition, our secondary screens identified the mismatch repair protein MSH2 as positively selected, consistent with our recent data suggesting that APOBEC3A-mediated mutagenesis is mediated by MMR activity, resulting in the characteristic omikli pattern of clustered mutations[7]. In contrast, UNG, MSH2 or other MMR proteins, were not identified as strong influencers of the survival of HMCES KO cells in the absence of A3A or DNA damage in our screens, or in recent screens performed by others in HMCES KO cells in a HEK293 background[76].…”
Section: Discussionsupporting
confidence: 90%
See 2 more Smart Citations
“…In addition, our secondary screens identified the mismatch repair protein MSH2 as positively selected, consistent with our recent data suggesting that APOBEC3A-mediated mutagenesis is mediated by MMR activity, resulting in the characteristic omikli pattern of clustered mutations[7]. In contrast, UNG, MSH2 or other MMR proteins, were not identified as strong influencers of the survival of HMCES KO cells in the absence of A3A or DNA damage in our screens, or in recent screens performed by others in HMCES KO cells in a HEK293 background[76].…”
Section: Discussionsupporting
confidence: 90%
“…TP53 status was shown to have a major influence on CRISPR/Cas9 survival screens and it is intuitive that checkpoint status would limit toxic DNA damage generated during S-phase and prevent mitotic catastrophe resulting from under-replicated DNA entering mitosis[78]. As A3A-mediated damage of ssDNA is S-phase specific, our results would again be consistent with the recently proposed model that HMCES shields AP-sites in ssDNA from processing by BER endonucleases that would generate AP-sites and toxic DSBs, or from replication by TLS polymerases that would result in increased mutagenesis[27,42,43,49,76]. As the enzymatic activities of HMCES have been implicated in this function, accumulating data suggests that targeting HMCES would be an attractive strategy for the specific sensitization of A3A-expressing, TP53-deficient cancers.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…In contrast to the above model, a recent study has shown that AP endonucleases may act in concert with HMCES for the resolution of AP sites. This study suggested that the HMCES-DPC may help to recruit AP endonuclease to channel these lesions to the proper repair pathway ( 145 ). In support of this, AP sites are known to react with several proteins such as histones, KU heterodimer, human ribosomal protein S3, nucleoside diphosphate kinase, PARP1, and several others ( 146–152 ).…”
Section: Dna–protein Crosslinksmentioning
confidence: 96%
“…For example, if the AP site was to be processed on ssDNA, it would generate a detrimental DSB. Accordingly, HMCES-deficient cells rely on HR proteins for survival and accumulate DSBs upon APOBEC3 overexpression, which stimulates the formation of abasic sites [ 41 , 105 ]. Thus, by crosslinking to the AP site, HMCES might ensure that the AP site is not processed until gap filling synthesis has been completed and the lesion is safely located on dsDNA ( Fig.…”
Section: Replication-coupled Dpc Repairmentioning
confidence: 99%